You are here:
Dominik Modest becomes Managing Director and new…
“Together, we can make significant advances in…
Understanding Cancer – Empowering Knowledge
Gain…
At this year's annual reception, the German Cancer…
Würzburg, Germany – Biostatistics plays a key…
The first patient in the Phase I clinical trial…
Advanced, hard-to-treat cancers are among the…
The NCT is a long-term cooperation between the…
On July 1st, an international scientific symposium…
Personalized Oncology Begins with Diagnosis and…
